Michael Bscheider,
Group Leader
Michael Bscheider is a group leader at Roche pRED’s preclinical Investigative Safety department in Basel. In 2010, he graduated from LMU Munich Medical School with his thesis on innate immune recognition of viruses and fungi. After a postdoc at the TU Munich on the interplay of immunology and gut epithelium repair during bone marrow transplantation, he worked at Stanford to investigate the development and function of immune cells and lymphoid structures in a tissue-specific context. He now heads labs that aim to leverage in-vitro systems for early safety assessments in immunomodulating drug development.
|
|
|
